Redeye thinks the Q1 report was weak, but in line with Redeye's expectations.
Redeye states that the company has demonstrated excellent cost control during the first quarter of 2...
Redeye comments on Gasporox Q1'23 report which beat expectations across the board.
Redeye comments on Medivir’s first quarter report of 2023.
Redeye takes a positive stance towards Hexatronic following a solid Q1 and a sharp share price decli...
Redeye makes minor estimate revisions and updates its fair value range following Alelion’s Q1 report...
Redeye reiterates its fair value range following a deeper dive into the Q1 report.
Maven Wireless publicerade den 27 april 2023 bolagets delårsrapport för det första kvartalet 2023 oc...
Redeye retains its positive view of Hexatronic following a solid Q1 report, with EBITA beating our f...
Sales and EBITA way above expectations (+26% and +120%) Organic growth of +31%, EBITA margin of 6.
Q1 numbers softer, but it's a small quarter We push our market recovery assumptions back 11x '23e EV...
Postponed sales from Q4'22 boost Q1 sales Q1 was the strongest ever quarter in APAC, 55% growth Shar...
Q1 tyngdes av kostnader för att hantera kommande tillväxt och dåligt väder i US Ökade konsultkostnad...
Q1-rapporten signalerar en bra start på året trots ett osäkert marknadsläge Nettoomsättningen ökade ...
Production stop in F&MT affects Q1 Decommissioning a bright spot Report in line with ABGSCe when adj...
Dovre’s Q1 profitability came in above our estimates despite some softness in top line attributable ...
Detection Technology’s Q1 topline came in as expected.
Finnair’s Q1 results topped estimates as high unit yields drove passenger revenue.
Consti's net sales in Q1 amounted to EUR 68.9m, above our and consensus estimates (EUR 62.
Scanfil’s Q1 figures beat estimates even if expectations were already high.
